ePrints

Timing is everything: outcomes of allogeneic HSCT in adults with inborn errors of immunity

Lookup NU author(s): Dr Suzanne Elcombe, Dr Venetia BigleyORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

© The Author(s), under exclusive licence to Springer Nature Limited 2026. Outcomes following international MDT assessment of adult IEI patients for allogeneic HSCT suggest early referral is vital: patients considered too high risk for transplant have poor outcomes with a 3-year overall survival of 31%.

Publication metadata

Author(s): Orf K, Yousuf HA, Fox TA, Samsudeen N, Elcombe S, Campbell M, Jolles S, Conlon N, Chopra C, Tjon JM, Tholouli E, Thomas M, Devlin L, Stockdale C, Huissoon A, Tvedt TH, McDermott E, Storrar N, Hunter H, Ferrua F, Ghanta H, Neth O, Codero E, Mistry A, Shields A, Goddard S, Kwakernaak AJ, de Bree G, Taube F, Sockel K, Korholz J, Herling C, Klemann C, Singh V, Dobsinska V, Johnston S, Vaitla P, Ojaimi S, Sargur R, Paneesha S, Blunt D, Schade-Larsen C, Massey V, Gandhi S, Kacar M, Rorsman F, Savic S, Toth A, Leavis H, Carrabba M, Gordins P, Khan S, Bulley S, Tawana K, Daza-Cajigal V, Snowden J, Lowe DM, Kiani-Alikhan S, Uttenthal B, Anantharachagan A, Schuetz C, Patel SY, Laurence A, Burns SO, Bigley V, Morris EC

Publication type: Letter

Publication status: Published

Journal: Bone Marrow Transplantation

Year: 2026

Pages: Epub ahead of print

Online publication date: 10/07/2026

Acceptance date: 12/06/2026

ISSN (print): 0268-3369

ISSN (electronic): 1476-5365

Publisher: Springer Nature

URL: https://doi.org/10.1038/s41409-026-02941-x

DOI: 10.1038/s41409-026-02941-x

Share